The Second Nikkei Asian Conference:Renewal of Our Commitment to Fight against Communicable Diseases

The 2nd Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases
Toward Developing a Specific Action Plan

Epidemic of dengue fever in the Ebola hemorrhagic fever and Japan in the world scale spreading demonstrated that communicable disease can spread rapidly and present simultaneously around the world as a result of increasing and accelerating population migration and physical distribution transactions. Is not limited to this, in all communicable disease not only cause health problems but also lead to stagnation and cessation of business activities, thereby significantly affecting the social economy.
To minimize damage caused by these infections, drastic measures toward prevention should be implemented both domestically and through international cooperation.
Recognizing this, Nikkei Inc. and Nikkei Business Publications, Inc. held the 1st "Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases" in February 2014 in Okinawa, a hub city in Asia. All stakeholders in industry, government and academia were invited, including government agencies, organizations and academic societies involved in infection prevention in Japan and abroad. At the conference, participants reached an understanding that infectious diseases in Asia is one of the major risks affecting economic growth and people’s health in the region that urgently needs to be addressed. Based on this understanding, all participants agreed on the "Okinawa Communicable Diseases Statement 2014."
The statement expresses that Japan, which has extensive experience and human resources in infection prevention, public health and healthcare innovation, is expected to make further contributions. The statement also confirmed that, in view of its experience in eliminating filariasis and malaria as well as its geopolitical characteristics, Okinawa is expected to contribute at the forefront to further strengthen cooperation between Japan and other Asian countries and to serve as a center in Asia for infection prevention.
The 2nd Nikkei Asian Conference will be held with the aim of deepening the discussions that were held at the first conference in order to enhance cooperation and develop a more specific action plan.

In the 2nd conference, a specific action plan to address actions that Japan is expected to take as specified in the Okinawa Communicable Diseases Statement 2014 will be developed in cooperation with stakeholders participating from Japan and abroad. Discussions will continue until an implementation plan is developed, which will be presented in the "Okinawa Communicable Diseases Statement 2015." As with the 2014 statement, the 2015 statement will be widely disseminated in Japan and other countries in the Asian region to promote the importance of preventing infections and the necessity of cooperation in the Asian region so as to ensure Japan’s leadership in infection prevention.

Conference OverView

Date	January 16 (Fri) 2015 　8:55～21:00 (Doors open at 8:30) January 17 (Sat) 2015 　9:00～14:30 (Doors open at 8:30)
Venue	Okinawa Bankoku Shinryokan 1792 Kise, Nago-shi, Okinawa, 905-0026 TEL: +81-980-53-3155 FAX: +81-980-53-3163
Organizer	Nikkei Inc., Nikkei Business Publications, Inc.
In association with	Okinawa Prefectural Government
Support	Ministry of Economy, Trade and Industry Ministry of Education, Culture, Sports, Science and Technology Ministry of Foreign Affairs Ministry of Health, Labour and Welfare
Cosponsors	DAIICHI SANKYO COMPANY FUJIFILM Corporation TOYAMA CHEMICAL KIRIN HOLDINGS Mitsubishi Tanabe Pharma NIPRO Otsuka Pharmaceutical SARAYA SHIONOGI Sumitomo Chemical Sumitomo Dainippon Pharma Global Health Innovative Technology Fund
Admission	Free admission: Participants will be selected by a draw. Pre-registration for the draw is required. Confirmation of your participation will be sent by email.

Program

January 16 (Fri) 2015

14:30-15:30
8:30	Doors open
8:55-9:00	Opening remarks Kohei Osada Nikkei Inc. Director Nikkei Business Publications, Inc. President
9:00-9:10	Opening remarks Mr. Isho Urasaki Vice Governor of Okinawa
9:10-9:15	Opening remarks Ryosuke Harada Nikkei Inc. Managing Executive Officer, Global Business
9:15-9:30	Keynote speech (1): H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR
9:30-9:45	Keynote speech (2): Toward an Action Plan Dr. Nu Nu Tha, Advisor to the President Health Sector. Advisor Office of the President. REPUBLIC OF THE UNION OF MYANMAR
9:45-10:05	Keynote speech (3): WHO nosocomial infection prevention campaign Clean Care is Safer Care – Action Plan ～World Health Organization 1st Global Patient Safety Challenge～ Prof. Didier Pittet, MD, MS Director, Infection Control Programme, WHO Collaborating Centre on Patient Safety University of Geneva Hospitals, Switzerland, Programme Lead, WHO First Global Patient Safety Challenge: Clean Care is Safer Care
10:05-10:25	Keynote speech (4): Possible to end AIDS, TB and Malaria? - Challenge of The Global Fund - Prof. Osamu Kunii, MD, MPH, PhD, Head, Strategy, Investment and Impact Division,The Global Fund to Fight AIDS, Tuberculosis and Malaria
10:25-10:35	Break
10:35-10:45	Opening remarks "Objectives and orientation of the Second Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases" <Chair> Dr. Shigeru Omi, MD, PhD, President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific <Co-Chair> Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization
10:45-12:05	Panel Discussion I: "Current measures and issues of communicable diseases" "WHO-driven measures against global and Asian communicable diseases" "Current report on communicable diseases in Asian countries - what issues should be solved through collaboration with Japan?" <Panelists> Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand Dr. Masato Tashiro, MD, PhD, Former Director, Influenza Virus Research Center, National Institute of Infectious Diseases Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia Dr. Norio Sugaya, MD, Dep. of Pediatrics, Dep. of Infection Control, Keiyu Hospital Dr. Nguyen Tran Hien, MD, MPH, PhD, Director, National Institute of Hygiene and Epidemiology Hanoi, Vietnam Chairman, Department of Epidemiology, Hanoi Medical University Dr. Mohamad Subuh MPPM, Director General Directorate General Of Disease Control and Environment Health Department Minister Of Health, Republic of Indonesia <Moderator> Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology
12:05-12:50	Lunch
12:50-14:20	Panel Discussion II-1: <<Tuberculosis control>> <Global Measures against tuberculosis; Current status and issues.> <Panelists> Dr. Hiroshi Ishikawa Fellow，Medicinal Chemistry, Otsuka Pharmaceutical Co., Ltd. Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia Dr. Mercy Ahun Special Representative for GAVI Eligible Countries Prof. Osamu Kunii, MD, MPH, PhD Head, Strategy, Investment and Impact Division, The Global Fund to Fight AIDS, Tuberculosis and Malaria Mr. Yasuyoshi Mori Manager, Biochemical Research Loboratory-II, Eiken Chemical Co.,Ltd. <Moderator> Dr. Tadao Shimao, MD, PhD, Adviser, Japan Anti-Tuberculosis Association
14:20-14:30	Break
14:30-15:30	Sectional meeting (1): Technical Support for Vietnam and contribution for Asia via JICA presented by Daiichi Sankyo Company, Ltd . <Panelists> Dr. Fumihiko Takeshita, M.D., Ph.D. Senior Director Vaccine Business Strategy Department, Vaccine Business Intelligence Division, DAIICHI SANKYO CO. Ltd. Mr. Yoshiharu Yoneyama Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc. Dr. Nobuhiko Okabe, MD, Ph.D. Director General, Kawasaki City Institute for Public Health Dr. Nguyen Tran Hien, MD, MPH, PhD, Director, National Institute of Hygiene and Epidemiology Hanoi, Vietnam Chairman, Department of Epidemiology, Hanoi Medical University Dr. Masahiko Kikuchi, Ph.D. Vice President, Vaccine Business Intelligence Division Vaccine Business Strategy Department in Daiichi Sankyo Co., Ltd. Member of the Board, Kitasato Daiichi Sankyo Vaccine Co., Ltd. Member of the Board (outside), Japan Vaccine Co., Ltd. Dr. Nguyen Dang Hien MD. PhD Director, Center for Research and Production of Vaccines and Biologicals (POLYVAC) <Moderator> Dr. Norihito Ueda, MD, Ph.D. Senior Director, Vaccine Business Strategy Department, Daiichi Sankyo (DS) & Head of R&D Division, Kitasato Daiichi Sankyo Vaccine (KDSV)	Sectional meeting (2): For international medical base formation of the infection measures Presented by Okinawa Prefectural Government <Panelists> Mr. Kiyoaki Gushiken Deputy Director General in charge of Planning Promotion Department of Planning Okinawa Prefectural Government Dr. Hideki Kuniyoshi Deputy Director General in charge of Health and Sanitation Department of Public Health and Medical Care Okinawa Prefectural Government Dr. Kuniaki Nerome, CEO, The Institute of Biological Resources <Commentator> Mr. Direk Limmathurotsakul, MD DLSTMH PhD Head of Microbiology Department, Mahidol-Oxford Tropical Medicine Research Unit (MORU) University, Thailand <Moderator> Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus
15:30-16:30
15:30-16:30	Sectional meeting (3): Asean Patient Safety Challenge ～WHO "Clean Care is Safer Care" ～ Presented by Saraya Co., Ltd. <Presenters> Prof. Didier Pittet, MD, MS Director, Infection Control Programme, WHO Collaborating Centre on Patient Safety University of Geneva Hospitals, Switzerland, Programme Lead, WHO First Global Patient Safety Challenge: Clean Care is Safer Care H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR Prof. Dr. Nwe Nwe Oo, Director General, Department of Health Planning, Ministry of Health, Myanmar Mr.Yusuke Saraya,President, SARAYA Co., LTD <Moderator> Mr. Yoshiharu Yoneyama Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency	Sectional meeting (4): Drug-resistance: Current status and countermeasures against it in Asia Presented by Shionogi & Co., Ltd. <Panelists> Dr. Yasuyoshi Ike MD. PhD. Extraordinary Professor, Department of Bacteriology, Gunma University Graduate School of Medicine Representative Director, Association for Education in Bacterial-Drug Resistance Prof. Zheng Bo Division of Infectious Diseases, Peking University First Hospital. The deputy director on academic committee of China antimicrobial resistance surveillance system Mr. Kasamatsu Yoshiharu Director, Head of Adequate Use of Anti-infective Agent Team Global Business Division SHIONOGI & CO., Ltd. <Moderator> Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus
16:30-16:40	Break
16:40-18:10	Panel discussion II-2<<Tuberculosis control>> Discussion on issues raised in panel discussion II-1 and to create road map for extermination of tuberculosis with of public sector and government sector collaboration. <Moderator> Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine ＜Discussants＞ H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia Dr. Mohamad Subuh MPPM, Director General Directorate General Of Disease Control and Environment Health Department Minister Of Health, Republic of Indonesia Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia Dr. Mercy Ahun Special Representative for GAVI Eligible Countries. Dr. Sharon Chan, Head of Asia, Aeras, Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization Dr. Hajime Inoue, MD, MPH, Director, Infectious Disease Control Division, Ministry of Health, Labour and Welfare Dr. Hiroshi Ishikawa Fellow，Medicinal Chemistry, Otsuka Pharmaceutical Co., Ltd. Mr. Masuhiro Yoshitake, Executive Operating Officer, Global Project Leader of TB Projects, Otsuka Pharmaceutical Co.,Ltd. Mr. Hiroshi Yoshida Member of the Board, R&D, Nipro Co. Dr. Fumihiko Takeshita, M.D., Ph.D. Senior Director Vaccine Business Strategy Department, Vaccine Business Intelligence Division, DAIICHI SANKYO CO. Ltd. Mr. Yasuyoshi Mori Manager, Biochemical Research Loboratory-II, Eiken Chemical Co.,Ltd. Dr. Atsushi Tsuchida, Ph.D. Board Director, Create Vaccine Co., Ltd. and Director, Global Business Development, Sumitomo Dainippon Pharma Co., Ltd.
18:10-19:10	Panel discussion III: Peer into the formation of infection prevention infrastructure in Japan and collaboration with Asia, Okinawa's roles, and detailed actions <Panelists> Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus Dr. Takashi Hirano, Ph.D. Founder and CTO, Okinawa Institute of Advanced Sciences Dr. Katsuaki Shinohara, PhD. Senior researcher, Division of Biosafety Control and Research, National Institute of Infectious Diseases <Moderator> Dr. Masato Tashiro, MD, PhD, Former Director, Influenza Virus Research Center, National Institute of Infectious Diseases ＜Discussants＞ H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia Dr. Mohamad Subuh MPPM, Director General Directorate General Of Disease Control and Environment Health Department Minister Of Health, Republic of Indonesia Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia Dr. Hajime Inoue, MD, MPH, Director, Infectious Control Division, Ministry of Health, Labour and Welfare
19:20-21:00	Reception party

January 17 (Sat) 2015

8:30	Doors open
9:00-9:20	Special Lecture The Ebola Crisis : Japan's Immediate Action and Mid - & Long -Term Strategy - Recommendations from The LDP - Mr. Keizo Takemi, Liberal Democratic Party, Chair of Special Mission Committee on Global Health, Member, the House of Councilors
9:20-9:40	Keynote speech (5): "New Initiave for Medical Research and Development in Japan" Mr. Yutaka Hishiyama, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat
9:40-11:10	Panel discussion IV-1<<Ebola measures>> What actions are required for measures against Asian and global communicable diseases? <Panelists> Dr. Yasuhiro Suzuki MD PhD, Assistant Minister for Technical Affairs Minister's Secretariat, Ministry of Health, Labour and Welfare Dr. Nobuko Kurosaki MD, President of Specified Nonprofit Corporation Medecins Sans Frontieres (MSF) Japon Dr. Yasuyuki Kato, MD, MPH Chief of Devision of Preparedness and Emerging Infections, Disease Control and Prevention Center, National Center for Global Health and Medicine <Moderator> Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization <Discussants> H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine Mr. Yutaka Hishiyama, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA) Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology Mr. Yuzo Toda Director, Senior Vice president FUJIFILM Corporation Dr. Mercy Ahun Special Representative for GAVI Eligible Countries Mr. Yoshiharu Yoneyama Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency Dr. BT Slingsby, MD, PhD, MPH Chief Executive Officer, Global Health Innovative Technology Fund
11:10-12:10	Panel discussion IV-2:<<Ebola measures>> Development of a detailed roadmap for IV-1 <Moderator> Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc. ＜Discussants＞ H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia Prof. Kimiyasu Shiraki, MD, PhD. Professor and Chairman Department of Virology, University of Toyama Dr. Yasuhiro Suzuki MD PhD, Assistant Minister for Technical Affairs Minister's Secretariat, Ministry of Health, Labour and Welfare Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA) Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology Mr. Yuzo Toda Director, Senior Vice president FUJIFILM Corporation Dr. Nobuko Kurosaki MD, President of Specified Nonprofit Corporation Medecins Sans Frontieres (MSF) Japon Dr. Yasuyuki Kato, MD, MPH Chief of Devision of Preparedness and Emerging Infections, Disease Control and Prevention Center, National Center for Global Health and Medicine Dr. BT Slingsby, MD, PhD, MPH Chief Executive Officer, Global Health Innovative Technology Fund
12:10-12:40	The Nikkei Business Daily Editor in Chief Interview (Refreshments) Mr. Yuzo Toda Director, Senior Vice president FUJIFILM Corporation Yoichi Shinohara Editor-in-Chief, Nikkei Business Daily
12:40-14:20	Final Plenary Session Reports from the panel discussion and sectional meetings, discussion summary <Panelists> Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology Dr. Tadao Shimao, MD, PhD, Adviser, Japan Anti-Tuberculosis Association Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine Dr. Masato Tashiro, MD, PhD, Former Director, Influenza Virus Research Center, National Institute of Infectious Diseases Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc. Dr. Norihito Ueda, MD, Ph.D. Senior Director, Vaccine Business Strategy Department, Daiichi Sankyo (DS) & Head of R&D Division, Kitasato Daiichi Sankyo Vaccine (KDSV) Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus Mr. Yoshiharu Yoneyama Deputy Director General, and Group Director for Health 1, Human Development, Department, Japan International Cooperation Agency <Moderators> Dr. Shigeru Omi, MD, PhD, President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization
14:20-14:30	General Overview Dr. Kiyoshi Kurokawa Adjunet National Graduate Institute for Policy Studies Chairman, Health and Global Policy Institute
14:30	Close

<Organaizers>

<In Association with>

<Sponsors>

application form was closed.

Secretariat office for:

the 2nd Nikkei Asian Communicable Diseases Conference
PCO Works, Inc.
2F., Kanda Urban Bldg., 2-4-2 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048 JAPAN
E-mail: bpsemi_150116@pcoworks.jp
Tel: +81-3-6869-0713, Fax: +81-3-3291-3635

Conference OverView

Program

January 16 (Fri) 2015

Doors open

Opening remarks

Opening remarks

Opening remarks

Keynote speech (1):

Keynote speech (2):

Toward an Action Plan

Keynote speech (3):

WHO nosocomial infection prevention campaign Clean Care is Safer Care – Action Plan ～World Health Organization 1st Global Patient Safety Challenge～

Keynote speech (4):

Possible to end AIDS, TB and Malaria? - Challenge of The Global Fund -

Break

Opening remarks

"Objectives and orientation of the Second Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases"

Panel Discussion I: "Current measures and issues of communicable diseases" "WHO-driven measures against global and Asian communicable diseases"

"Current report on communicable diseases in Asian countries - what issues should be solved through collaboration with Japan?"

<Panelists>

<Moderator>

Lunch

Panel Discussion II-1: <<Tuberculosis control>>

<Global Measures against tuberculosis; Current status and issues.>

<Panelists>

<Moderator>

Break

Sectional meeting (1): Technical Support for Vietnam and contribution for Asia via JICA presented by Daiichi Sankyo Company, Ltd .

<Panelists>

<Moderator>

Sectional meeting (2): For international medical base formation of the infection measures Presented by Okinawa Prefectural Government

<Panelists>

<Commentator>

<Moderator>

Sectional meeting (3): Asean Patient Safety Challenge ～WHO "Clean Care is Safer Care" ～Presented by Saraya Co., Ltd.

<Presenters>

<Moderator>

Sectional meeting (4): Drug-resistance: Current status and countermeasures against it in Asia Presented by Shionogi & Co., Ltd.

<Panelists>

<Moderator>

Break

Panel discussion II-2<<Tuberculosis control>>

Discussion on issues raised in panel discussion II-1and to create road map for extermination of tuberculosis with of public sector and government sector collaboration.

<Moderator>

＜Discussants＞

Panel discussion III:

Peer into the formation of infection prevention infrastructure in Japan and collaboration with Asia, Okinawa's roles, and detailed actions

<Panelists>

<Moderator>

＜Discussants＞

Reception party

January 17 (Sat) 2015

Doors open

Special Lecture

The Ebola Crisis : Japan's Immediate Action and Mid - & Long -Term Strategy - Recommendations from The LDP -

Keynote speech (5):

"New Initiave for Medical Research and Development in Japan"

Panel discussion IV-1<<Ebola measures>>

What actions are required for measures against Asian and global communicable diseases?

<Panelists>

<Moderator>

<Discussants>

Panel discussion IV-2:<<Ebola measures>>

Development of a detailed roadmap for IV-1

<Moderator>

＜Discussants＞

The Nikkei Business Daily Editor in Chief Interview (Refreshments)

Final Plenary Session

Reports from the panel discussion and sectional meetings, discussion summary

<Panelists>

<Moderators>

General Overview

Close

Secretariat office for:

WHO nosocomial infection prevention campaign
Clean Care is Safer Care – Action Plan
～World Health Organization 1st Global Patient Safety Challenge～

Panel Discussion I: "Current measures and issues of communicable diseases"
"WHO-driven measures against global and Asian communicable diseases"

Sectional meeting (3): Asean Patient Safety Challenge ～WHO "Clean Care is Safer Care" ～
Presented by Saraya Co., Ltd.

Discussion on issues raised in panel discussion II-1
and to create road map for extermination of tuberculosis with of public sector and government sector collaboration.